News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
CeNes Pharmaceuticals (U.S.) Gets Takeover Approach
February 5, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON (Reuters) - Shares in CeNeS Pharmaceuticals surged on Tuesday after the firm said it was in talks that may lead to an offer for the company.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Mergers & acquisitions
UPDATE: Novo Nordisk Seeks To Steal Metsera From Pfizer With $8.5B Offer
October 30, 2025
·
4 min read
·
Annalee Armstrong
Podcast
Novartis’ Big Buy, Q3 Earnings, Regeneron’s Dropped Cell Therapy, More
October 29, 2025
·
1 min read
·
Heather McKenzie
Earnings
Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem
October 28, 2025
·
3 min read
·
Annalee Armstrong
Rare diseases
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition
October 27, 2025
·
2 min read
·
Tristan Manalac
